Skip to the page

Data / Form D filings / Elligint Health, Inc.

Elligint Health, Inc.: Form D filings

Elligint Health, Inc., a technology company in Edison, NJ, filed 3 Form D notices with the SEC in 2025. The latest, on June 27, 2025, reports $13.1 million sold of an offering with no set size to 56 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
343 THORNALL STREET, SUITE #630, Edison, NJ, 08837
Phone
(443) 995-2924
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2051403

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 27, 2025AmendmentIndefinite$13,123,83856Dec 27, 2024sec.gov
Jan 10, 2025New noticeIndefinite$13,123,83856Dec 27, 2024sec.gov
Jan 10, 2025New notice$4,200,000$3,200,000$1,000,0002Dec 27, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Adam SabloffDirector
Gregg MichaelsonDirector
Chris CaramanicoExecutive Officer, Director
Ashish KapoorDirector
Sumesh P. PoyilExecutive Officer
Lenard MarcusDirector
Enrico PicozzaDirector
Michael LudwigDirector
Steven TolleDirector
Danielle BellangerDirector

Other technology companies in New Jersey that filed recently

Every Form D from the week of Jun 23, 2025 · All recent filings in New Jersey · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Elligint Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.